GR Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$628K Buy
683
+116
+20% +$118K 0.21% 11
2025
Q4
$609K Buy
567
+1
+0.2% +$956 0.14% 14
2025
Q3
$432K Buy
566
+1
+0.2% +$744 0.1% 14
2025
Q2
$440K Sell
565
-4
-0.7% -$3.11K 0.11% 16
2025
Q1
$470K Buy
569
+1
+0.2% +$832 0.07% 13
2024
Q4
$438K Buy
568
+1
+0.2% +$828 0.07% 16
2024
Q3
$502K Buy
567
+1
+0.2% +$899 0.09% 6
2024
Q2
$512K Buy
566
+1
+0.2% +$800 0.11% 7
2024
Q1
$440K Buy
565
+12
+2% +$8.54K 0.1% 9
2023
Q4
$323K Sell
553
-33
-6% -$19.3K 0.11% 9
2023
Q3
$315K Buy
586
+1
+0.2% +$515 0.09% 8
2023
Q2
$274K Buy
585
+1
+0.2% +$419 0.09% 9
2023
Q1
$200K Buy
584
+2
+0.3% +$675 0.07% 11
2022
Q4
$213K Buy
+582
New +$206K 0.07% 10

Other funds holding LLY

GR Financial Group's LLY Position: Q1 2026 in Review

GR Financial Group increased its Eli Lilly (LLY) stake by 20% in Q1 2026, buying an estimated $118K and bringing the position to 683 shares worth $628K. The position accounts for 0.21% of the portfolio, ranked #11.

GR Financial Group first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • GR Financial Group held 683 shares of Eli Lilly worth $628K as of Q1 2026.
  • GR Financial Group bought 116 Eli Lilly shares in Q1 2026, an estimated $118K.
  • Eli Lilly made up 0.21% of GR Financial Group's portfolio in Q1 2026, its #11 holding.
  • GR Financial Group first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on GR Financial Group's 13F filing for Q1 2026, filed 11 May 2026.